ZNF350 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.57801999999263E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
9.50210000000284E-05 |
Normal-vs-Stage2 |
9.185700E-04 |
Normal-vs-Stage3 |
3.925900E-02 |
Normal-vs-Stage4 |
3.97009999997255E-06 |
Stage1-vs-Stage2 |
9.496000E-01 |
Stage1-vs-Stage3 |
4.572800E-01 |
Stage1-vs-Stage4 |
4.512300E-02 |
Stage2-vs-Stage3 |
4.687400E-01 |
Stage2-vs-Stage4 |
4.093800E-02 |
Stage3-vs-Stage4 |
3.475800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.46900000006245E-07 |
Normal-vs-AfricanAmerican |
1.664970E-01 |
Normal-vs-Asian |
2.124400E-01 |
Caucasian-vs-AfricanAmerican |
9.844400E-02 |
Caucasian-vs-Asian |
3.068800E-01 |
AfricanAmerican-vs-Asian |
9.942800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.21220000043532E-07 |
Normal-vs-Female |
8.921900E-02 |
Male-vs-Female |
1.617430E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.181610E-01 |
Normal-vs-Extreme_Weight |
6.46550000205082E-08 |
Normal-vs-Obese |
1.037320E-03 |
Normal-vs-Extreme_Obese |
1.978560E-01 |
Normal_Weight-vs-Extreme_Weight |
1.470000E-01 |
Normal_Weight-vs-Obese |
7.818800E-01 |
Normal_Weight-vs-Extreme_Obese |
7.816600E-01 |
Extreme_Weight-vs-Obese |
1.705690E-02 |
Extreme_Weight-vs-Extreme_Obese |
5.923200E-01 |
Obese-vs-Extreme_Obese |
8.580800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.024270E-02 |
Normal-vs-Age(41-60Yrs) |
1.362100E-04 |
Normal-vs-Age(61-80Yrs) |
4.31840000000294E-05 |
Normal-vs-Age(81-100Yrs) |
5.587600E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.635600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.003000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.688600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.927400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.417800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.903000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
9.15440000470724E-08 |
Normal-VS-Type2 PRCC |
1.95349999998484E-06 |
Normal-VS-KIRP CIMP |
5.284200E-01 |
Normal-VS-Unclassified PRCC |
2.383500E-03 |
Type1 PRCC-VS-Type2 PRCC |
9.997400E-01 |
Type1 PRCC-VS-KIRP CIMP |
1.453530E-02 |
Type1 PRCC-VS-Unclassified PRCC |
2.650800E-01 |
Type2 PRCC-VS-KIRP CIMP |
4.780000E-02 |
Type2 PRCC-VS-Unclassified PRCC |
3.849800E-01 |
KIRP CIMP-VS-Unclassified PRCC |
1.820160E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
9.37870000550234E-08 |
Normal-vs-N1 |
2.104800E-01 |
Normal-vs-N2 |
6.22869533728476E-11 |
N0-vs-N1 |
1.361840E-02 |
N0-vs-N2 |
1.60780999999277E-05 |
N1-vs-N2 |
8.19419999964488E-07 |
|
|